These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative efficacies of mezlocillin and ampicillin alone or in combination with gentamicin in the treatment of Streptococcus faecalis endocarditis in rabbits. Fass RJ, Wright CA. Antimicrob Agents Chemother; 1984 Apr; 25(4):408-10. PubMed ID: 6428306 [Abstract] [Full Text] [Related]
8. Daptomycin (LY146032) treatment of experimental enterococcal endocarditis. Bush LM, Boscia JA, Kaye D. Antimicrob Agents Chemother; 1988 Jun; 32(6):877-81. PubMed ID: 2843085 [Abstract] [Full Text] [Related]
9. Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis. Pavleas J, Skiada A, Daikos GL, Pefanis A, Giamarellos-Bourboulis E, Kanellakopoulou K, Tsaganos T, Perrea D, Donta I, Karayannakos P, Giamarellou H. J Chemother; 2008 Apr; 20(2):208-12. PubMed ID: 18467247 [Abstract] [Full Text] [Related]
12. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis. Lafaurie M, Perichon B, Lefort A, Carbon C, Courvalin P, Fantin B. Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476 [Abstract] [Full Text] [Related]
13. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A. J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251 [Abstract] [Full Text] [Related]
14. Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Hindes RG, Willey SH, Eliopoulos GM, Rice LB, Eliopoulos CT, Murray BE, Moellering RC. Antimicrob Agents Chemother; 1989 Jul; 33(7):1019-22. PubMed ID: 2506803 [Abstract] [Full Text] [Related]
15. Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci. Hellinger WC, Rouse MS, Rabadan PM, Henry NK, Steckelberg JM, Wilson WR. Antimicrob Agents Chemother; 1992 Jun; 36(6):1272-5. PubMed ID: 1416826 [Abstract] [Full Text] [Related]
16. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Lavoie SR, Wong ES, Coudron PE, Williams DS, Markowitz SM. Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374 [Abstract] [Full Text] [Related]
17. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance. Kak V, Donabedian SM, Zervos MJ, Kariyama R, Kumon H, Chow JW. Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613 [Abstract] [Full Text] [Related]